Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75,607 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bioequivalence of paclitaxel protein-bound particles in patients with breast cancer: determining total and unbound paclitaxel in plasma by rapid equilibrium dialysis and liquid chromatography-tandem mass spectrometry.
Li J, Li W, Dai X, Zhong D, Ding Y, Chen X. Li J, et al. Among authors: li w. Drug Des Devel Ther. 2019 May 20;13:1739-1749. doi: 10.2147/DDDT.S200679. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31190752 Free PMC article. Clinical Trial.
Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial.
Wang D, Fu B, Peng Z, Yang D, Han M, Li M, Yang Y, Yang T, Sun L, Li W, Shi W, Yao X, Ma Y, Xu F, Wang X, Chen J, Xia D, Sun Y, Dong L, Wang J, Zhu X, Zhang M, Zhou Y, Pan A, Hu X, Mei X, Wei H, Xu X. Wang D, et al. Among authors: li w, li m. Front Med. 2021 Jun;15(3):486-494. doi: 10.1007/s11684-020-0824-3. Epub 2021 Mar 9. Front Med. 2021. PMID: 33687643 Free PMC article. Clinical Trial.
The efficacy and safety of dupilumab in Chinese patients with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled study.
Zhao Y, Wu L, Lu Q, Gao X, Zhu X, Yao X, Li L, Li W, Ding Y, Song Z, Liu L, Dang N, Zhang C, Liu X, Gu J, Wang J, Geng S, Liu Q, Guo Y, Dong L, Su H, Bai L, O'Malley JT, Luo J, Laws E, Mannent L, Ruddy M, Amin N, Bansal A, Ota T, Wang M, Zhang J. Zhao Y, et al. Among authors: li w, li l. Br J Dermatol. 2022 Apr;186(4):633-641. doi: 10.1111/bjd.20690. Epub 2021 Oct 21. Br J Dermatol. 2022. PMID: 34358343 Free PMC article. Clinical Trial.
Risk Factor Analysis for AKI Including Laboratory Indicators: a Nationwide Multicenter Study of Hospitalized Patients.
Nie S, Feng Z, Tang L, Wang X, He Y, Fang J, Li S, Yang Y, Mao H, Jiao J, Liu W, Cao N, Wang W, Sun J, Shao F, Li W, He Q, Jiang H, Lin H, Fu P, Zhang X, Liu Y, Wu Y, Xi C, Liang M, Qu Z, Zhu J, Wu G, Zheng Y, Na Y, Li Y, Li W, Cai G, Chen X. Nie S, et al. Among authors: li s, li y, li w. Kidney Blood Press Res. 2017;42(5):761-773. doi: 10.1159/000484234. Epub 2017 Oct 24. Kidney Blood Press Res. 2017. PMID: 29136619 Free article.
Efficacy and Safety of Jueyin Granules for Patients with Mild-to-Moderate Psoriasis Vulgaris: Protocol for a Multicenter Randomized Placebo-Controlled Trial.
Li S, Zhang C, Zhang HY, Zhou M, Wang SN, Xu R, Zhou DM, Ji YR, Lv JJ, Yin QF, Wang RP, Li W, Liu YP, Wang JF, Li B, Li X. Li S, et al. Among authors: li w, li x, li b. Evid Based Complement Alternat Med. 2020 Apr 9;2020:8942301. doi: 10.1155/2020/8942301. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32351609 Free PMC article.
75,607 results
You have reached the last available page of results. Please see the User Guide for more information.